Compounds > pyridostigmine bromide
Page last updated: 2024-08-18

pyridostigmine bromide and Polycystic Ovary Syndrome

pyridostigmine bromide has been researched along with Polycystic Ovary Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, M; Flyvbjerg, A; Frystyk, J; Glintborg, D; Hagen, C; Hermann, AP; Støving, RK; Veldhuis, JD1
Huh, KB; Lee, BS; Lee, EJ; Lee, HC; Park, KH; Song, CH1

Trials

1 trial(s) available for pyridostigmine bromide and Polycystic Ovary Syndrome

ArticleYear
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:10

    Topics: Absorptiometry, Photon; Adult; Area Under Curve; Body Composition; Cholinesterase Inhibitors; Double-Blind Method; Female; Gonadal Steroid Hormones; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Menstruation; Pioglitazone; Polycystic Ovary Syndrome; PPAR gamma; Pyridostigmine Bromide; Stimulation, Chemical; Thiazolidinediones

2005

Other Studies

1 other study(ies) available for pyridostigmine bromide and Polycystic Ovary Syndrome

ArticleYear
Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome.
    Fertility and sterility, 1993, Volume: 60, Issue:1

    Topics: Adolescent; Adult; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Polycystic Ovary Syndrome; Premedication; Pyridostigmine Bromide

1993